The impact of FDG-PET in the management of patients with salivary gland malignancy

Annals of Nuclear Medicine

Volumn 19, Issue 8, 2005, Pages 691-694

  Otsuka, Hideki ^a,b   Graham, Michael M ^a   Kogame, Masahiro ^b   Nishitani, Hiromu ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

FDG PET; Patient management; Salivary gland malignancy

Indexed keywords

FLUORODEOXYGLUCOSE;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; LYMPHOEPITHELIOMA; MALE; MELANOMA; PLEOMORPHIC ADENOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SALIVARY GLAND CANCER; SALIVARY GLAND DUCT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SALIVARY GLAND NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 31744446149     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02985118     Document Type: Article

References (7)

1. Schoder H, Yeung HWD, Gonen M, Larson SM. Head and Neck Cancer: Clinical Usefulness and Accuracy of PET/CT Image Fusion. Radiology 2004; 231: 65-72.
2. Teknos TN, Rosenthal EL, Lee D, Taylor R, Marn CS. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck 2001; 23: 1056-1060.
3. Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman MM, Wahl RL. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology 2005; 234: 879-885.
4. Keyes JW Jr, Harkness BA, Greven KM, Williams DW 3rd, Watson NE Jr, McGuirt WF. Salivary gland tumors: pretherapy evaluation with PET. Radiology 1994; 192: 99-102.
5. Okamura T, Kawabe J, Koyama K, Ochi H, Yamada R, Sakamoto H, et al. Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Imaging of Parotid Mass Lesions. Acta Otolaryngol 1998; 538: 209-213.
6. Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, et al. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med 2005; 30: 170-176.
7. Yoshikai T, Ishimaru J, Satoh T, Inokuchi A, Kudo S. The limitations of gallium scintigraphy in the differentiation between benign and malignant salivary gland mass lesions. Nucl Med Commun 2003; 24: 657-662.